Related references
Note: Only part of the references are listed.Cerebrospinal fluid biomarkers for Parkinson's disease - a systematic review
A. D. Andersen et al.
ACTA NEUROLOGICA SCANDINAVICA (2017)
CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study
Ju-Hee Kang et al.
ACTA NEUROPATHOLOGICA (2016)
Alpha-Synuclein as a Biomarker for Parkinson's Disease
Anzari Atik et al.
BRAIN PATHOLOGY (2016)
Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders
Brit Mollenhauer et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Cerebrospinal α-synuclein in α-synuclein aggregation disorders: tau/α-synuclein ratio as potential biomarker for dementia with Lewy bodies
Franc Llorens et al.
JOURNAL OF NEUROLOGY (2016)
Presence of cerebral amyloid modulates phenotype and pattern of neurodegeneration in early Parkinson's disease
Corey T. McMillan et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression
Nour K. Majbour et al.
MOVEMENT DISORDERS (2016)
The BioFIND Study: Characteristics of a Clinically Typical Parkinson's Disease Biomarker Cohort
Un Jung Kang et al.
MOVEMENT DISORDERS (2016)
Biomarkers in Parkinson's disease: Advances and strategies
Marion Delenclos et al.
PARKINSONISM & RELATED DISORDERS (2016)
Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson's disease patients
Wenyan Kang et al.
SCIENTIFIC REPORTS (2016)
Parkinson disease with REM sleep behavior disorder Features, α-synuclein, and inflammation
Yang Hu et al.
NEUROLOGY (2015)
Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease
Ane Lovli Stay et al.
PARKINSONISM & RELATED DISORDERS (2015)
Associations between Cerebrospinal Fluid Biomarkers and Cognition in Early Untreated Parkinson's Disease
Ragnhild E. Skogseth et al.
JOURNAL OF PARKINSONS DISEASE (2015)
Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease
Min Shi et al.
ACTA NEUROPATHOLOGICA (2014)
CSF Aβ42 predicts early-onset dementia in Parkinson disease
Guido Alves et al.
NEUROLOGY (2014)
Submandibular gland needle biopsy for the diagnosis of Parkinson disease
Charles H. Adler et al.
NEUROLOGY (2014)
How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale
Glenn T. Stebbins et al.
MOVEMENT DISORDERS (2013)
Cerebrospinal Fluid Biomarkers for Parkinson Disease Diagnosis and Progression
Min Shi et al.
ANNALS OF NEUROLOGY (2011)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study (vol 10, pg 230, 2011)
B. Mollenhauer et al.
LANCET NEUROLOGY (2011)
Cerebrospinal Fluid Tau/α-Synuclein Ratio in Parkinson's Disease and Degenerative Dementias
Lucilla Parnetti et al.
MOVEMENT DISORDERS (2011)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
Brit Mollenhauer et al.
LANCET NEUROLOGY (2011)
DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease
Zhen Hong et al.
BRAIN (2010)
Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia
Jonathan Wills et al.
EXPERIMENTAL NEUROLOGY (2010)
CSF amyloid-β and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study
Guido Alves et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
CSF Aβ42 and tau in Parkinson's Disease with Cognitive Impairment
Thomas J. Montine et al.
MOVEMENT DISORDERS (2010)
CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease
A. Siderowf et al.
NEUROLOGY (2010)
Cerebrospinal Tau, Phospho-Tau, and Beta-Amyloid and Neuropsychological Functions in Parkinson's Disease
Yaroslau Compta et al.
MOVEMENT DISORDERS (2009)
Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale Presentation and Clinimetric Testing Results
Christopher G. Goetz et al.
MOVEMENT DISORDERS (2008)
Red blood cells are the major source of alpha-synuclein in blood
Robin Barbour et al.
NEURODEGENERATIVE DISEASES (2008)
The REM sleep behavior disorder screening questionnaire -: A new diagnostic instrument
Karin Stiasny-Kolster et al.
MOVEMENT DISORDERS (2007)
Interaction between Aβ peptide and α synuclein:: Molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease
Pravat K. Mandal et al.
NEUROCHEMICAL RESEARCH (2006)
The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment
ZS Nasreddine et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
Initiation and synergistic fibrillization of tau and alpha-synuclein
BI Giasson et al.
SCIENCE (2003)
Share Paper
